Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03870334
Recruitment Status : Not yet recruiting
First Posted : March 12, 2019
Last Update Posted : May 6, 2021
Sponsor:
Information provided by (Responsible Party):
Landos Biopharma Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : January 2022